Amvuttra (vutrisiran)

pCPA File Number: 22562
Negotiation Status:
Concluded with an LOI
Indication(s):
Hereditary transthyretin-mediated amyloidosis
Sponsor/Manufacturer:
Alnylam Netherlands B.V.
CDA-AMC Project Number:
SR0801-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: